Irritable Bowel Syndrome and Antidepressants

被引:3
作者
Curtiss, Frederic R. [1 ]
机构
[1] Acad Managed Care Pharm, Alexandria, VA 22314 USA
来源
JOURNAL OF MANAGED CARE PHARMACY | 2008年 / 14卷 / 09期
关键词
D O I
10.18553/jmcp.2008.14.9.882
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:882 / 885
页数:4
相关论文
共 31 条
[1]
Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable Bowel syndrome in adolescents [J].
Bahar, Ron J. ;
Collins, Brynie S. ;
Steinmetz, Barry ;
Ament, Marvin E. .
JOURNAL OF PEDIATRICS, 2008, 152 (05) :685-689
[2]
CAMILLERI M, 2008, GASTROENTEROLOG 1008
[3]
UNITED-STATES HOUSEHOLDER SURVEY OF FUNCTIONAL GASTROINTESTINAL DISORDERS - PREVALENCE, SOCIODEMOGRAPHY, AND HEALTH IMPACT [J].
DROSSMAN, DA ;
LI, ZM ;
ANDRUZZI, E ;
TEMPLE, RD ;
TALLEY, NJ ;
THOMPSON, WG ;
WHITEHEAD, WE ;
JANSSENS, J ;
FUNCHJENSEN, P ;
CORAZZIARI, E ;
RICHTER, JE ;
KOCH, GG .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (09) :1569-1580
[4]
Eoff JC, 2008, J MANAGE CARE PHARM, V14, pS3
[5]
Irritable bowel syndrome subtypes differ in body awareness, psychological symptoms and biochemical stress markers [J].
Eriksson, Elsa M. ;
Andren, Kristina I. ;
Eriksson, Henry T. ;
Kurlberg, Gran K. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (31) :4889-4896
[6]
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation [J].
Evans, B. W. ;
Clark, W. K. ;
Moore, D. J. ;
Whorwell, P. J. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04)
[7]
IRRITABLE-BOWEL-SYNDROME IN OFFICE-BASED PRACTICE IN THE UNITED-STATES [J].
EVERHART, JE ;
RENAULT, PF .
GASTROENTEROLOGY, 1991, 100 (04) :998-1005
[8]
Self-Reported Use of Pharmaceuticals Among Patients With Irritable Bowel Syndrome in Primary Care [J].
Faresjo, Ashild ;
Grodzinsky, Ewa ;
Johansson, Saga ;
Wallander, Mari-Ann ;
Faresjo, Tomas ;
Timpka, Toomas .
JOURNAL OF MANAGED CARE PHARMACY, 2008, 14 (09) :870-877
[9]
Treatment of irritable bowel syndrome - Strategies involve single receptor blockade and non-pharmacological interventions [J].
Farthing, MG .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7489) :429-+
[10]
*FDA CDER, FDA PUBL HLTH ADV TE